SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharma - Quaterly Results

21 May 2022 Evaluate
The Sales for the quarter ended March 2022 of Rs. 3.03 million declined by -83.93% from Rs. 18.85 millions.A big loss of -79.07% reported for the quarter ended March 2022 to Rs. 0.09  millions from Rs. 0.43 millions.The Operating Profit of the company witnessed a decrease to 0.10 millions from 0.28 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 3.03 18.85 -83.93 39.39 85.51 -53.94 39.39 85.51 -53.94
Other Income 0.15 0.00 0.00 0.15 0.26 -42.31 0.15 0.26 -42.31
PBIDT 0.10 0.28 -64.29 1.52 1.33 14.29 1.52 1.33 14.29
Interest 0.00 0.00 0.00 0.03 0.00 0.00 0.03 0.00 0.00
PBDT 0.10 0.28 -64.29 1.49 1.33 12.03 1.49 1.33 12.03
Depreciation 0.01 0.11 -90.91 0.09 0.45 -80.00 0.09 0.45 -80.00
PBT 0.09 0.17 -47.06 1.40 0.88 59.09 1.40 0.88 59.09
TAX 0.00 -0.26 0.00 -0.05 -0.05 0.00 -0.05 -0.05 0.00
Deferred Tax 0.00 -0.05 0.00 -0.05 -0.05 0.00 -0.05 -0.05 0.00
PAT 0.09 0.43 -79.07 1.45 0.93 55.91 1.45 0.93 55.91
Equity 102.69 102.69 0.00 102.69 102.69 0.00 102.69 102.69 0.00
PBIDTM(%) 3.30 1.49 122.18 3.86 1.56 148.09 3.86 1.56 148.09

Pharmaids Pharma Share Price

30.50 -0.42 (-1.36%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×